BACKGROUND: Controversy remains regarding the benefits of sentinel lymph node (SLN) biopsy for predicting survival in cutaneous melanoma of the head and neck (CMHN). METHODS: We analyzed the factors associated with the recurrence and survival of CMHN patients treated in our institution. RESULTS: One hundred thirteen patients underwent SLN biopsy for CMHN in a 12-year period. SLN identification was successful in 96%, with a median of 3 SLNs per patient. Positive-SLNs were identified in 21%. With a median follow-up of 34 months, 28% recurred. Disease-free survival (DFS) and overall survival (OS) rates were 66% and 78% in patients with SLN-negative, and 39% and 62% in SLN-positive disease. In multivariate analysis, greater Breslow-thickness was associated with decreased DFS rate (HR 2.07, CI 1.04-4.09), and age>60 years (HR 3.53, CI 1.32-9.4) with lower 5-year OS rate. CONCLUSION: Primary tumor thickness and age were associated with decreased survival, whereas SLN status showed a trend for prognostic significance in CMHN. Copyright (c) 2008 Wiley Periodicals, Inc. Head Neck 2008.
BACKGROUND: Controversy remains regarding the benefits of sentinel lymph node (SLN) biopsy for predicting survival in cutaneous melanoma of the head and neck (CMHN). METHODS: We analyzed the factors associated with the recurrence and survival of CMHN patients treated in our institution. RESULTS: One hundred thirteen patients underwent SLN biopsy for CMHN in a 12-year period. SLN identification was successful in 96%, with a median of 3 SLNs per patient. Positive-SLNs were identified in 21%. With a median follow-up of 34 months, 28% recurred. Disease-free survival (DFS) and overall survival (OS) rates were 66% and 78% in patients with SLN-negative, and 39% and 62% in SLN-positive disease. In multivariate analysis, greater Breslow-thickness was associated with decreased DFS rate (HR 2.07, CI 1.04-4.09), and age>60 years (HR 3.53, CI 1.32-9.4) with lower 5-year OS rate. CONCLUSION:Primary tumor thickness and age were associated with decreased survival, whereas SLN status showed a trend for prognostic significance in CMHN. Copyright (c) 2008 Wiley Periodicals, Inc. Head Neck 2008.
Authors: Danique M S Berger; Nynke S van den Berg; Vincent van der Noort; Bernies van der Hiel; Renato A Valdés Olmos; Tessa A Buckle; Gijs H KleinJan; Oscar R Brouwer; Lenka Vermeeren; Baris Karakullukçu; Michiel W M van den Brekel; Bart A van de Wiel; Omgo E Nieweg; Alfons J M Balm; Fijs W B van Leeuwen; W Martin C Klop Journal: J Nucl Med Date: 2021-02-26 Impact factor: 10.057
Authors: Brian R Gastman; Jonathan S Zager; Jane L Messina; Robert W Cook; Kyle R Covington; Brooke Middlebrook; Pedram Gerami; Jeffrey D Wayne; Sancy Leachman; John T Vetto Journal: Head Neck Date: 2019-01-29 Impact factor: 3.147
Authors: John E Hanks; Kevin J Kovatch; S Ahmed Ali; Emily Roberts; Alison B Durham; Joshua D Smith; Carol R Bradford; Kelly M Malloy; Philip S Boonstra; Christopher D Lao; Scott A McLean Journal: Otolaryngol Head Neck Surg Date: 2020-02-11 Impact factor: 3.497
Authors: Hidde J Veenstra; W Martin C Klop; Maarten J Speijers; Peter J F M Lohuis; Omgo E Nieweg; Harald J Hoekstra; Alfons J M Balm Journal: Ann Surg Oncol Date: 2012-05-11 Impact factor: 5.344
Authors: Victoria M L Cohen; Maria Tsimpida; John L Hungerford; Hikmat Jan; Rino Cerio; Graeme Moir Journal: Br J Ophthalmol Date: 2013-09-24 Impact factor: 4.638